Health Care Supplies

HUALAN NPM

HUALAN NPM released FY2026 Q4 earnings on April 23 (BJT), actual revenue CNY 129.56 M, actual EPS CNY 0.004

HUALAN NPM released FY2025 annual earnings on April 23 After-Market (BJT), actual revenue CNY 619.45 M (forecast CNY 730.01 M), actual EPS CNY 0.367 (forecast CNY 0.525)

HUALAN NPM released FY2025 Q4 earnings on April 23 After-Market (BJT), actual revenue CNY 178.21 M, actual EPS CNY 0.0418

HUALAN NPM released FY2026 Q1 earnings on April 23 After-Market BJT, actual revenue CNY 129.56 M, actual EPS CNY 0.004

HUALAN NPM FY2026 Q1 Earnings Release on April 24 After-Market (BJT)

HUALAN NPM to Release FY2025 Earnings on April 24 After-Market (BJT), Forecast Revenue CNY 730.01 M, EPS CNY 0.525

HUALAN NPM released FY2025 Q3 earnings on October 22 After-Market (BJT), actual revenue CNY 132.48 M, actual EPS CNY 0.0569

HUALAN NPM released FY2025 9 Months Earnings on October 22 After-Market (BJT), actual revenue CNY 441.24 M, actual EPS CNY 0.3271

HUALAN NPM to Release FY2025 Q3 Earnings on October 23 After-Market (BJT)

HUALAN NPM released FY2025 Semi-Annual Earnings on August 26 Pre-Market (BJT), actual revenue CNY 308.76 M, actual EPS CNY 0.27

HUALAN NPM released FY2025 Q2 earnings on August 26 Pre-Market (BJT), actual revenue CNY 163.18 M, actual EPS CNY 0.1581

HUALAN NPM to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

Kaiyuan Securities Maintains Buy Rating on Huashan Shares

Huilan Shares ESG Rating Rises to BBB

Huaron Shares Plans to Repurchase Shares

Huaron Shares Co-Found Joint Venture with Dan Yexing

Rui Zhen Life Insurance Plans to Reduce Holdings in Huaran Shares by Up to 3.00%

Huaron Shares 2025 Q1 Net Profit Up 72.10%

HUALAN NPM released FY2025 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 145.58 M, actual EPS CNY 0.1123

Huaron Shares Signs Strategic Cooperation Agreement with Ganli Pharma

600959

301093

000995

Since November, multiple A-share listed companies have announced shareholding increase plans. Huangtai Wine's controlling shareholder intends to increase holdings by 70 million to 140 million yuan, JSCN's controlling shareholder plans to increase holdings by 100 million to 150 million yuan, and HUALAN NPM's controlling shareholder aims to increase holdings by 30 million to 60 million yuan. According to statistics, as of November 19, the total amount of shareholding increases by important shareholders of A-share companies has exceeded 93 billion yuan this year, setting a new high since 2023. (Securities Times)

36Kr

JSCN

Huangtai Wine

In the year, important shareholders increased their holdings by over 93 billion yuan, setting a new high since 2023

According to the Qichacha APP, recently, Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd. was established with a registered capital of 50 million yuan. The business scope includes: artificial intelligence industry application system integration services; artificial intelligence application software development; artificial intelligence public data platform; artificial intelligence basic software development, etc. Qichacha's equity penetration shows that the company is wholly owned by HUALAN NPM

Zhitong

HUALAN NPM newly established a smart pharmaceutical technology company, including AI business

HUALAN NPM released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 441 million yuan, a year-on-year increase of 4.36%. The net profit attributable to the parent company was 53.316 million yuan, a year-on-year increase of 2.06%. The net profit after deducting non-recurring gains and losses was 40.8258 million yuan, a year-on-year increase of 13.66%. The basic earnings per share were 0.325 yuan

HUALAN NPM released its performance for the first three quarters, with a net profit attributable to the parent company of 53.316 million yuan, an increase of 2.06%

HUALAN NPM announced that the revenue for the third quarter was 132 million yuan, a year-on-year decrease of 4.72%; the net profit was 9.5839 million yuan, a year-on-year decrease of 37.20%. The revenue for the first three quarters was 441 million yuan, a year-on-year increase of 4.36%; the net profit was 53.316 million yuan, a year-on-year increase of 2.06%

HUALAN NPM: Net profit in the third quarter was 9.5839 million yuan, a year-on-year decrease of 37.20%

According to the Zhitong Finance APP, HUALAN NPM announced that the company plans to use its own funds of 50 million yuan to invest in establishing a wholly-owned subsidiary in Hainan Province. The main business scope of this wholly-owned subsidiary will be: research and development solutions and services for innovative drugs in artificial intelligence

HUALAN NPM plans to establish a subsidiary in Hainan with an investment of 50 million yuan, focusing on research and development solutions and services for innovative drugs in artificial intelligence

HUALAN NPM announced the establishment of a wholly-owned subsidiary, Nanjing Renqing Mianqu Health Technology Co., Ltd., with an investment of 5 million yuan to support the company's strategic layout and industrial development. The subsidiary has completed its business registration and will be included in the company's consolidated financial statements. This move aims to develop new business growth points, expand influence, and promote the healthy development of the company

HUALAN NPM established Nanjing Renqing Mianqu Health Technology Co., Ltd

HUALAN NPM's shareholder Ruizhong Life disclosed a reduction plan on May 12, 2025, planning to reduce holdings by no more than 3,789,267 shares from June 4 to September 3. As of September 3, Ruizhong Life reduced its holdings by 1,263,000 shares through centralized bidding, accounting for 0.7692%. This reduction did not result in a change of control of the company and did not have a significant impact on the company's governance and operations

HUALAN NPM: Shareholder Ruizhong Life's reduction plan has expired, reducing 0.7692% of shares

According to the Zhitong Finance APP, HUALAN NPM released its semi-annual report for 2025, showing an operating income of 309 million yuan, a year-on-year increase of 8.82%. The net profit attributable to shareholders of the listed company was 43.7321 million yuan, a year-on-year increase of 18.27%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.8196 million yuan, a year-on-year increase of 42.18%. The basic earnings per share were 0.27 yuan

HUALAN NPM released its performance for the first half of the year, with a net profit attributable to the parent company of 43.7321 million yuan, an increase of 18.27%

HUALAN NPM signed a shareholder agreement with Ms. Dan Yexing to establish a joint venture company, primarily engaged in the research, production, and sales of products such as Tibetan medicinal baths and plasters. The registered capital of the joint venture company is 7 million yuan, with HUALAN NPM contributing 4.298 million yuan, accounting for 61.4%. This investment aims to promote HUALAN NPM's strategic layout and industrial development, facilitating the company's healthy growth

HUALAN NPM plans to establish a joint venture company to operate products such as Tibetan medicinal baths and plasters

According to the announcement from HUALAN NPM, the major shareholder Ruizhong Life Insurance Co., Ltd. plans to reduce its holdings of the company's shares by no more than 3.7893 million shares (accounting for 3.00% of the company's total share capital) through centralized bidding and block trading within three months after the announcement of this reduction plan, starting from June 4, 2025, to September 3, 2025 (no reduction during the window period)

HUALAN NPM(301093.SZ)